Small molecule screening identifies targetable zebrafish pigmentation pathways
- Authors
- Colanesi, S., Taylor, K.L., Temperley, N.D., Lundegaard, P.R., Liu, D., North, T.E., Ishizaki, H., Kelsh, R.N., and Patton, E.E.
- ID
- ZDB-PUB-120125-11
- Date
- 2012
- Source
- Pigment cell & melanoma research 25(2): 131-143 (Journal)
- Registered Authors
- Kelsh, Robert, Lundegaard, Pia Rengtved, North, Trista, Patton, E. Elizabeth
- Keywords
- pigment cell, melanocyte, iridophore, small molecule, development, screen, zebrafish
- MeSH Terms
-
- Animals
- Cell Count
- Chromatophores/cytology
- Chromatophores/drug effects
- Cyclooxygenase Inhibitors/pharmacology
- Drug Evaluation, Preclinical
- Embryo, Nonmammalian/drug effects
- Embryo, Nonmammalian/metabolism
- Heterocyclic Compounds, 3-Ring/pharmacology
- Melanocytes/cytology
- Melanocytes/drug effects
- Metabolic Networks and Pathways/drug effects*
- Phenotype
- Pigmentation/drug effects*
- Purines/pharmacology
- Pyrimidinones/pharmacology
- Small Molecule Libraries/analysis*
- Small Molecule Libraries/pharmacology*
- Tyrphostins/pharmacology
- Zebrafish/embryology
- Zebrafish/metabolism*
- PubMed
- 22252091 Full text @ Pigment Cell Melanoma Res.
Small molecules complement genetic mutants and can be used to probe pigment cell biology by inhibiting specific proteins or pathways. Here, we present the results of a screen of active compounds for those that affect the processes of melanocyte and iridophore development in zebrafish, and investigate the effects of a few of these compounds in further detail. We identified and confirmed 57 compounds that altered pigment cell patterning, number, survival or differentiation. Additional tissue targets and toxicity of small molecules are also discussed. Given that the majority of cell types, including pigment cells, are conserved between zebrafish and other vertebrates, we present these chemicals as molecular tools to study developmental processes of pigment cells in living animals, and emphasize the value of zebrafish as an in vivo system for testing the on and off-target activities of clinically active drugs.